Octopus Biosafety's EBIT per Share for the
six
months ended in Dec. 2024 was €-0.06.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.06.
During the past 3 years, the average EBIT per Share Growth Rate was 49.00% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 45.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Octopus Biosafety's EBIT per Share or its related term are showing as below:
STU:OCR'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -250.7 Med: 39.2 Max: 49
Current: 49
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Octopus Biosafety was 49.00% per year. The lowest was -250.70% per year. And the median was 39.20% per year.
STU:OCR's 3-Year EBIT Growth Rate is ranked better than 89.18% of 1959
companies
in the Hardware industry
Industry Median: 2.9
vs STU:OCR: 49.00
Octopus Biosafety (STU:OCR) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Octopus Biosafety EBIT per Share Related Terms
Octopus Biosafety EBIT per Share Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (STU:OCR) has a EBIT per Share of €-0.06 as of Dec. 2024. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #212 out of 1959 companies in the Hardware industry, placing it in the top 10.8%.
Is Octopus Biosafety's EBIT per Share too high?
Octopus Biosafety's current EBIT per Share is €-0.06. Based on the distribution chart, Octopus Biosafety ranks #212 out of 1959 companies in the Hardware industry, which is in the top quartile — a strong position relative to peers. Overall, Octopus Biosafety has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's EBIT per Share compare to SNDK and DELL?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #212 out of 1959 companies for EBIT per Share. This places Octopus Biosafety in the top 11% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 2.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Hardware company?
The median EBIT per Share among Hardware companies is 2.90, based on 1,959 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median EBIT per Share is 2.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current EBIT per Share is €-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current EBIT per Share of €-0.06. The stock's GF Value™ is €0.04, compared to a current price of €0.10 — trading 150% above its estimated fair value. The current EBIT per Share is €-0.06. Octopus Biosafety's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current EBIT per Share is €-0.06 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.10 is trading 150% above its estimated GF Value™ of €0.04.
Key valuation signals for STU:OCR:
EBIT per Share: €-0.06
GF Value™: €0.04 vs. price of €0.10 (150% above fair value)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
6GF Score
Get the complete analysis for STU:OCR
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
